This inventor holds 26 USPTO granted patents and 17 published patent applications and 2 EPO patents, primarily in Gold CAR T-Cell Therapy. Top assignees: Chimera Bioengineering, Inc., Eastman Chemical Company, Chimera Bioengingeering, Inc.. Active years: 2012-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Mountain View, CA (US) (2012 - 2016)
- Menko Park, CA (US) (2019)
- Menlo Park, CA (US) (2017 - 2023)
Company Filing History:
21 out of 21 
3 out of 2,039 
1 out of 1 Years Active: 2012-2026
Areas of Expertise:
Title: The Innovative Contributions of Benjamin Wang in Biotechnological Patents
Introduction: Benjamin Wang, located in Menlo Park, California, is a prolific inventor with a remarkable portfolio of 21 patents. His work primarily focuses on developing groundbreaking methods in the field of biotechnology, particularly emphasizing antigen binding domains and innovative therapeutic strategies.
Latest Patents: Among his most recent inventions, Benjamin Wang has contributed significantly to two notable patents. The first patent titled "Methods for making novel antigen binding domains" explores techniques to create new antigen binding domains aimed at combating infectious diseases. This invention also encompasses novel CARs (Chimeric Antigen Receptors) that utilize these binding domains as extracellular elements, positioning them as promising therapeutic agents. The second patent, "Combination therapy with gold controlled transgenes," reveals control devices that integrate RNA destabilizing elements (RDEs) with transgenes, including CARs in eukaryotic cells. This innovation optimizes the expression of transgenes, allowing for targeted therapeutic interventions, especially in conjunction with anticancer therapies.
Career Highlights: Benjamin Wang has held significant positions in various innovative firms, prominently at Chimera Bioengineering, Inc. His inventive work at this company has propelled advancements in the biotechnology sector and has led to several patent filings that underline his expertise.
Collaborations: Throughout his career, Benjamin has collaborated with notable colleagues such as Gusti Zeiner and Krista McNally, contributing to a dynamic work environment that fosters creativity and the development of innovative solutions in biotechnology.
Conclusion: Benjamin Wang exemplifies the spirit of innovation within the field of biotechnology. With a strong patent portfolio and impactful collaborations, his contributions continue to advance the development of novel therapies, showcasing his role as a pivotal inventor in the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile